BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23215730)

  • 1. Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients.
    Muro Y; Sugiura K; Akiyama M
    Autoimmunity; 2013 Jun; 46(4):279-84. PubMed ID: 23215730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.
    Tarricone E; Ghirardello A; Rampudda M; Bassi N; Punzi L; Doria A
    J Immunol Methods; 2012 Oct; 384(1-2):128-34. PubMed ID: 22884621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
    Muro Y; Ishikawa A; Sugiura K; Akiyama M
    Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.
    Peterson LK; Jaskowski TD; La'ulu SL; Tebo AE
    Immunol Res; 2018 Jun; 66(3):431-436. PubMed ID: 29845587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis.
    Betteridge ZE; Gunawardena H; Chinoy H; North J; Ollier WE; Cooper RG; McHugh NJ;
    Ann Rheum Dis; 2009 Oct; 68(10):1621-5. PubMed ID: 18930994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report.
    Nainia K; Aouzal MA; Ouafik I; Charhbili M; Bouchhab A; Daoudi A; Tizki S; Chakiri R
    Pediatr Rheumatol Online J; 2024 May; 22(1):57. PubMed ID: 38773611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2.
    Ishikawa A; Muro Y; Sugiura K; Akiyama M
    Rheumatology (Oxford); 2012 Jul; 51(7):1181-7. PubMed ID: 22427409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
    Jia E; Wei J; Geng H; Qiu X; Xie J; Xiao Y; Zhong L; Xiao M; Zhang Y; Jiang Y; Zhang J
    Clin Rheumatol; 2019 Aug; 38(8):2189-2193. PubMed ID: 31030362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in dermatomyositis-specific autoantibodies.
    Fujimoto M; Watanabe R; Ishitsuka Y; Okiyama N
    Curr Opin Rheumatol; 2016 Nov; 28(6):636-44. PubMed ID: 27533321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts.
    Ge Y; Lu X; Shu X; Peng Q; Wang G
    Sci Rep; 2017 Mar; 7(1):188. PubMed ID: 28298642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
    Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
    Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.
    Demortier J; Vautier M; Chosidow O; Gallay L; Bessis D; Berezne A; Cordel N; Schmidt J; Smail A; Duffau P; Jachiet M; Begon E; Gottlieb J; Chasset F; Graveleau J; Marque M; Cesbron E; Forestier A; Josse S; Kluger N; Beauchêne C; Le Corre Y; Pagis V; Rigolet A; Guillaume-Jugnot P; Authier FJ; Guilain N; Streichenberger N; Leonard-Louis S; Boussouar S; Landon-Cardinal O; Benveniste O; Allenbach Y
    Rheumatology (Oxford); 2023 Dec; 62(12):3932-3939. PubMed ID: 37010495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: A potential unique subset of dermatomyositis-associated interstitial lung disease.
    Gono T; Tanino Y; Nishikawa A; Kawamata T; Hirai K; Okazaki Y; Shibata Y; Kuwana M
    Int J Rheum Dis; 2019 Aug; 22(8):1582-1586. PubMed ID: 31050194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
    J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients.
    Kang EH; Kuwana M; Okazaki Y; Lee EY; Lee YJ; Lee EB; Song YW
    Mod Rheumatol; 2014 Nov; 24(6):945-8. PubMed ID: 24670134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P; Barman P; Basu S; Mondal S; Ishran B; Kumrah R; Dod A; Garg R; Rawat A; Singh S
    Immunol Res; 2023 Feb; 71(1):112-120. PubMed ID: 36278969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T; Tani Y; Okiyama N; Mizuochi K; Ichimura Y; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):34. PubMed ID: 33740993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.